Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity.

× No keyword cloud information.

47 in total

1. Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma.

Authors: Jason Konner; Rachel N Grisham; Jae Park; Owen A O'Connor; Gillian Cropp; Robert Johnson; Alison L Hannah; Martee L Hensley; Paul Sabbatini; Svetlana Mironov; Svetlana Miranov; Samuel Danishefsky; David Hyman; David R Spriggs; Jakob Dupont; Carol Aghajanian
Journal: Invest New Drugs Date: 2011-11-10 Impact factor: 3.850

2. The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice.

Authors: T C Chou; O A O'Connor; W P Tong; Y Guan; Z G Zhang; S J Stachel; C Lee; S J Danishefsky
Journal: Proc Natl Acad Sci U S A Date: 2001-07-03 Impact factor: 11.205

3. Nanomolar concentrations of epothilone D inhibit the proliferation of glioma cells and severely affect their tubulin cytoskeleton.

Authors: A Dietzmann; D Kanakis; E Kirches; S Kropf; C Mawrin; K Dietzmann
Journal: J Neurooncol Date: 2003-11 Impact factor: 4.130

4. Design and synthesis of C6-C8 bridged epothilone A.

Authors: Weiqiang Zhan; Yi Jiang; Peggy J Brodie; David G I Kingston; Dennis C Liotta; James P Snyder
Journal: Org Lett Date: 2008-03-21 Impact factor: 6.005

5. A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumors.

Authors: J Paul Monk; Miguel Villalona-Calero; Joe Larkin; Greg Otterson; David S Spriggs; Alison L Hannah; Gillian F Cropp; Robert G Johnson; Martee L Hensley
Journal: Invest New Drugs Date: 2011-08-09 Impact factor: 3.850

6. Differentiating between models of epothilone binding to microtubules using tubulin mutagenesis, cytotoxicity, and molecular modeling.

Authors: Ruth A Entwistle; Rania S Rizk; Daniel M Cheng; Gerald H Lushington; Richard H Himes; Mohan L Gupta
Journal: ChemMedChem Date: 2012-07-16 Impact factor: 3.466

7. Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy.

Authors: Dae Hwan Shin; Glen S Kwon
Journal: Int J Pharm Date: 2017-01-03 Impact factor: 5.875

8. Total synthesis and evaluation of C26-hydroxyepothilone D derivatives for photoaffinity labeling of beta-tubulin.

Authors: Emily A Reiff; Sajiv K Nair; John T Henri; Jack F Greiner; Bollu S Reddy; Ramappa Chakrasali; Sunil A David; Ting-Lan Chiu; Elizabeth A Amin; Richard H Himes; David G Vander Velde; Gunda I Georg
Journal: J Org Chem Date: 2010-01-01 Impact factor: 4.354

9. Microtubule stabilization opposes the (TNF-alpha)-induced loss in the barrier integrity of corneal endothelium.

Authors: Mahesh Shivanna; Sangly P Srinivas
Journal: Exp Eye Res Date: 2009-08-18 Impact factor: 3.467

10. A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanoma.

Authors: Patrick A Ott; Anne Hamilton; Amanda Jones; Naomi Haas; Tsiporah Shore; Sandra Liddell; Paul J Christos; L Austin Doyle; Michael Millward; Franco M Muggia; Anna C Pavlick
Journal: PLoS One Date: 2010-01-20 Impact factor: 3.240